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A b s t r a c t  
Attempts are made in research and development of sustained and controlled drug delivery systems 
to overcome physiological and unpredictable gastric empting time (GET). Such dosage forms are 
useful for the drugs with Ânarrow therapeutic index'. Formation of gel depends on factors such as 
temperature, pH, ionic cross linking and UV irradiation, from which drug is released in controlled or 
sustained manner. In-situ gelling systems is prominent among other novel drug delivery systems 
(NDDS), due to advantages such as sustained and prolonged drug action, improved patient 
compliance and reduced frequency of drug administration as compared to conventional drug 
delivery system. These polymeric formulations are in solution form before administration and then 
turns to gel form when comes in contact with gastric fluids. Various natural, biodegradable, 
biocompatible and water soluble polymers such as pectin, gallen gum, chitosan, poly-caprolactone, 
xyloglucane, poly-D, L-lactic acid, pluronic F 127, carbopol, etc makes this drug delivery most 
acceptable and useful. In-situ gel is fabricated for both local and systemic drug delivery at specific 
site of action. Various evaluations are recommended for in-situ gels mostly viscosity, buoyancy, 
gelling capacity and dissolution studies are performed. This review presents current trends in 
fabrication, evaluation parameters and importance of various drugs formulated as in-situ gelling 
system.  
Keywords: Hollow microspheres, Multiparticulate floating system, peroral delivery, Gastro retentive 
floating DDS. 
Introduction 
Floating is the Novel Drug Delivery System. Different dosage form 
are developed in gastro retentive floating system as microspheres, 
micro beads, tablets, capsules, films etc. In-situ gelling system is a 
new trend in floating DDS. In-situ gelling system have its 
application in different routes of administration like oral, nasal, 
ophthalmic, peroral ,rectal,  vaginal and also parenteral route. In-
situ forming polymeric drug delivery systems has many advantages 
such as ease of administration, increased local bioavailability, 
reduced dose frequency, improved patient compliance and has 
less complex method of production and so is cost effective. [1, 2] 
Gastro retentive FDDS have bulk density lower than gastric fluid 
and hence remain buoyant in stomach without affecting the gastric 
emptying rate for a long period of time. When the gel so formed 
float on gastric fluid the drug get released slowly at desired rate 
from the floating gel. After drug is released from floating system, 
the residual part is emptied from stomach. This may increase GRT 
and also control the fluctuations in plasma drug concentration 
(PCD). Floating system are the controlled or sustained release 
dosage form and have properties similar to hydrophilic matrices 
and so called as hydrodynamically balanced system (HBS) as they 
form a low density polymeric gel barrier at outer surface.   Drug is 
slowly released from the matrices same as that in case of 
conventional hydrophilic matrices.  This form may remain buoyant 
(8-10 hours) on gastric contents without affecting the rate of gastric 
empting. Different polymer systems are used in floating drug 
delivering dosage forms. Among those some are polysaccharides, 
polymethacrylates, hydrocolloids etc. in this cellulose ether 
polymers are most popular, especially HPMC. The formulation of 
floating in situ gelling solution may sustain and prolong drug action, 
improve patient compliance and reduce frequency of administration 
of the drug in comparison to conventional drug delivery system. [3-7] 
Different Applications Of In-Situ Gelling Drug Delivery 
System  
Parenteral delivery 
It is most obvious way to provide sustained release medication is to 
place the drug in a delivery system and inject or implant the system 
into the body tissue. Poloxamers are predominantly used in these 
preparations to obtain the thermo reversible gel. Suitability of 
poloxamer gel alone or with combination with HPMC, Na-CMC or 
dextran was studied for epidural administration of drug in-vitro. 
Dang Wang et al (2014) prepared and developed a parenteral 
thermo-sensitive organogel or ganogel for treatment of 
schizophrenia by using long chain fatty acids in pharmaceutical oil. 
[8, 9] 
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Ocular delivery  
Ophthalmic hydrogel have its efficacy based on increased ocular 
residence time via enhancing viscosity and mucoadhesive 
properties. In situ gels are preferred since they are conveniently 
dropped in the eye as a solution where it undergoes transition to 
for a gel.  Thermo sensitive, specific ion sensitive or pH-sensitive 
hydrogels have been examined for their potential as vehicles for 
ocular drugs. Gellan gum containing formulations of pilocarpine 
HCl reduces drug concentration from 2% to 0.5% showing the 
same bioavailability. Gellan containing formulations of pilocarpine 
HCl allowed reduction of drug concentration from 2% to 0.5% 
obtaining the same bioavailability.10 Malik APH et al (2014) 
studied pH induced in-situ gelling system of an anti-infective drug 
i.e. gatifloxacin for sustain ocular delivery.[11] Lin T formulated 
another new in-situ gelling formulation consisting of 0.15% 
ganciclovir (GCV) for herpes simplex keratitis. They evaluated 
clinically the safety and efficacy of the ganciclovir. [13] 
Rectal delivery 
For the rectal administration all the drugs used as liquid, semisolid 
(ointments, creams or foams), and solid dosage form 
(suppositories) can be used. Suppositories cause discomfort during 
insertion which is minimized in case of in-situ preparations. Novel 
in-situ gelling liquid suppositories which form gel at temperature 
near 30-36oC are developed using poloxamers 407 and/or 
poloxamer 188 to obtain the temperature sensitive gelation 
property. Thermo reversible xyloglucan gels are useful for rectal 
drug delivery. Lin HR et al (2012) developed a novel in-situ gelling 
liquid suppository for site-targeting delivery of anti-colorectal 
cancer drugs.25 
Vaginal delivery  
Thermoplastic graft copolymers develops in-situ gelation to prolong 
the release of active ingredients such asnonoxynol-9, progestins, 
estrogens, peptides and proteins. Mucoadhesive thermo sensitive 
gel containing combination of poloxamers and polycarbophil 
exhibited prolonged antifungal activity of clotrimazol compared to 
conventional formulation. Sayed I et  al  studied development and 
characterization of thermosensitive pluronic-based Metronidazole 
in-situ gelling formulations for vaginal application. [29]  
Peroral delivery  
The pH sensitive hydrogel have potential use in site-specific drug 
delivery to a particular region of stimuli sensitive hydrogels in 
controlled and sustained drug delivery to GI tract.  Cross-linked 
hydrogels with faster swelling under high pH conditions, likewise 
other polysaccharides such as amidaded pectin, guar gum and 
insulin were investigated in order to develop a potential colon 
specific drug delivery system. Rao PB studied the in-situ 
mucoadhesive peroral delivery of antifungal drug voriconazole for 
treatment of candidiasis using carbopol 934P and HPMC E50 
polymers as independent variables. Formulation showed drug 
release up to 12 hrs. Haoping Xu developed a novel in-situ gel for 
formulation of ranitidine for oral sustained delivery.[36] Rao PBet al 
(2014) Design optimization and evaluation of mucoadhesive 
peroral in-situ gel containing anti fungal drug for candidiasis.[37] 
Dermal and Transdermal delivery 
Thermally reversible gel of Pluronic F127 was evaluated as vehicle 
for the percutaneous administration of indomethacin. In- vivo study 
suggest that 20% w/w aqueous gel may be of practical use as a 
base for topical administration of drug. Poloxamer 407 was found 
to be suitable for transdermal delivery of insulin. The combination 
of chemical enhancers and iontophoresis result in synergistic 
enhancement of insulin permeation. Pillai O et al (2003) studied 
Transdermal delivery of insulin from poloxamer gel: ex vivo and in 
vivo skin permeation studies in rat using iontophoresis and 
chemical enhancers.[39] 
Nasal delivery  
An in-situ gelling system for nasal delivery of mometasone furoare 
was developed and evaluated for the treatment of allergic rhinitis. 
Xanthan gum and gellan gum is used as gelling polymers. In situ 
gel was found to inhibit the increase in nasal symptoms as 
compared to marketed formulation nasonex. Pre-clinical studies 
demonstrated that the hydrogel formulation to decrease the blood 
glucose concentration by 40-50% of initial valves for 4-5 hrs after 
administration with no apparent cytotoxicity. Therefore, these types 
of systems are best suited for protein and peptide drug delivery. 
Abhirami M studied recently the nasal in-situ gelling system for 
administration of celecoxib to enhance its bioavailability and drug 
activity. The complex of drug was formed with β-cyclodextrin and 
polymer used where Pluronic F127 and carbopol934P. The 
addition of cyclodextrin complexed drug in formulation prove 
enhancement in dissolution of hydrophobic drug in aqueous 
environment which increases in-vivo bioavailability of drug. [42] 
Anuradha Nerella prepared the in-situ mucoadhesive nasal gel of 
montelukast sodium used in leukotriene antagonist used in 
treatment of asthma and allergic rhinitis. This formulation reduces 
the pre-systemic metabolism and is attractive alternative.[43] 
Mechanism Of Floating System  
Various attempts are made to obtain retention of dosage form in 
stomach by increasing RT of stomach. These include introduction 
of different gastro retentive dosage forms as floating system (gas 
generating system and swelling and expanding system), 
mucoadhesive system, high density systems, modified shape 
systems, gastric-empting delaying devices and co-administration of 
gastric empting delaying drugs. From this the floating drug delivery 
system (FDDS) is most commonly used. FDDS have a bulk density 
less than gastric fluids and so remain buoyant in the stomach 
without affecting the gastric emptying rate for a prolong period of 
time. When the system floats on gastric contents the drug is 
released slowly at the desire rate from the system. After the drug is 
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released, the residue is emptied from the stomach. This results in 
increasing the gastric empting time of stomach as well as 
controlling the fluctuations in PDC. [45] 
 
F = F buoyancy- F gravity= (Df- Ds) gv--- (1) 
Where,  
 F= total vertical force,  
Df = fluid density 
Ds = object density 
V= volume 
G= acceleration due to gravity 
 
 
Figure.1. Mechanism of floating systems, GF= Gastric fluid  
 
Formation Of In Situ Gelation Mechanism 
These are aqueous liquid preparations that are in liquid state 
before administration, and turns to gel under physiological 
conditions. Different mechanisms which lead to in situ gel formation 
are:  
Ionic cross-linking 
pH change  
Temperature modulation 
Polymers such as gellan gum, pectin and sodium alginate etc 
contains divalent ions which are complexed with sodium citrate 
which are braked down in acidic environment of stomach to release 
free divalent ions (Ca+2) that causes in situ gelation of oral 
solution. It forms double helical junctions by aggregating double 
helical segments to form a dimensional network by complexation 
with cations and hydrogen bonding with water. 
 
Figure.2 a) Different layers i) Semi-permeable membrane, ii) Core pill layer, b) Mechanism of floatation via CO2 generation.  
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Based on the Mechanism of Buoyancy FDDS can be 
Classified as 
A. Single unit floating systems 
a) Effervescent system (Gas-generating system) 
b) Non-effervescent system 
B. multiple unit floating systems 
a) Effervescent system (Gas-generating system) 
b) Non-effervescent system 
c) Microspheres 
C. Raft forming system 
A. Single unit floating system 
Effervescent Systems (Gas-generating Systems) 
Effervescent systems utilizes matrices prepared with polymers like 
HPMC, polysaccharides as chitosan, effervescent agent as sodium 
bicarbonate, citric acid and tartaric acid or chambers that contains 
liquid which gasifies at body temperature. The optimum ratio of 
stiochiometry for citric acid and sodium bicarbonate to generate 
gas is reported to be 0.76:1. The resin beads of sodium 
bicarbonate coated with ethyl cellulose is a common method of 
preparation of these systems.  The water permeation is possible 
from the coat which is insoluble but permeable one. Thus CO2 is 
released which causes beads to float on the gastric fluid. Most 
commonly used excipients in such systems are polyacrylate 
polymers, polyvinyl acetate, HPMC, carbopol, sodium alginate, 
agar, calcium chloride, polyethylene oxide and polycarbonates. [47] 
Non-effervescent systems  
Due to imbibitions of gastric fluid this system swells upon 
swallowing and it also prevent their exit from the stomach. These 
systems are like plug as they are having tendency to remain 
lodged near to the polymeric sphincter. These dosage forms 
involves the mixing of drug with gels which has tendency to swell 
when comes in contact with gastric fluid when administered orally 
and maintains a relative integrity of shape and the bulk density less 
than one in a outer gelatinous barrier. The air trapped in polymer 
matrix give buoyancy to the dosage forms. These systems involve 
different types as microporous compartment, alginate beads, 
colloidal gels, hollow microspheres etc. Another system which 
incorporates the gas filled chamber in microporous compartment 
which consist of a drug reservoir which is fluid- filled floating 
chamber. On top and bottom of the walls different openings or 
apertures are present from which the GI fluids get entered into the 
chamber and drug diffuses slowly from it. The other two walls are 
sealed to undissolve the drug therein. The fluid present in it may be 
air in partial vacuum or other suitable sources as gases, liquids or 
solids having inert behavior and appropriate specific gravity. The 
device is swellowable and remain in the floating state for prolong 
period of time. After the drug is completely released the shell get 
disintegrate, passes to intestine and then get eliminated. 47 
Multiple Units Floating System  
To overcome the drawbacks of the hydrodynamically balanced 
system or floating systems are the variability in GI transit time then 
administered orally. Thus to overcome this problem the multiple 
unit floating system were developed, which reduce the inter-subject 
variability in absorption and minimize the probability of dose 
dumping. Research has been made in field of hollow microspheres 
which are capable of floating on GI fluid and also increase the 
gastric retention property. 
Non-effervescent systems  
Much work is not performed on non-effervescent multiple unit 
system in comparison to effervescent system. Some researchers 
have reported the possibility of developing systems containing 
indomethacin by using chitosan as polymer. Indomethacin in 
multiple unit HBS is a model drug prepared by extrusion process is 
already reported. The extrudate of mixture (drug, chitosan and 
acetic acid) is extruded though needle, then cut and dried.  
Chitosan hydrates and float in the acidic medium and the required 
multiple drug release could be obtained by modifying the drug 
polymer ratio. [47-48] 
Effervescent Systems(Gas-generating system) 
Floating minicapsules of pepstatin having diameter of 0.1-0.2 mm 
has been reported by Umezawa. These minicapsules contain a 
central core and a coating and the central core consist of granules 
composed of sodium bicarbonate, lactose and a binder which is 
coated with HPMC layer. Ikura et al reported sustained release 
floating granules containing tetracycline hydrochloride. A multiple 
unit system prepared by Iannuccelli et al comprises of calcium 
alginate core and calcium alginate/PVA membrane, both separated 
by air compartment. In presence of water, the PVA leaches out and 
increases the membrane permeability, maintaining the integrity of 
the air compartment. Ichikawa et al developed a new multiple type 
of floating dosage system having a pill in the core, composed of 
effervescent layers and swellable membrane layers coated on 
sustained release pills. [49, 50, 51] 
Hollow Microsphere  
Hollow microspheres are considered as one of the most promising 
buoyant systems, as they possess the unique advantages of 
multiple unit systems as well as better floating properties, because 
of central hollow space inside the microspheres. The techniques 
involved in the preparation include simple solvent evaporation, and 
solvent diffusion and evaporation. The drug release and floating 
property mainly depends on the type of polymer used, plasticizer 
and solvents used for preparation. Polymers such as 
polycarbonate, Eudragit S and cellulose acetate were used in the 
preparation of hollow microspheres, and the drug release can be 
modulated by optimizing the polymer quantity and the polymer-
plasticizer ratio. Semalty M. (2010) Prepared and characterized of 
floating microspheres of ofloxacin hydrochloride.52 
Shendge et al. International Journal of Drug Delivery 6 (3) 230-243 [2014] 
 
 
  
PAGE | 234 |
 
C. Raft forming system 
Raft forming systems are known for the delivery of antacids and 
drug delivery to GI infections or disorders. The formation of viscous 
cohesive gel in contact with gastric fluids, where each portion of 
liquid swells to form layer called raft is a main mechanism of its 
formation. The raft so formed floats on gastric fluids because of low 
bulk density created by CO2 release. The system contains a gel 
forming agent and alkaline bicarbonates or carbonates responsible 
for the formation of CO2 to make the system less dense and float 
on the gastric fluids. Jorgen et al describes an antacid raft forming 
floating system. The gel forming agents as gellan gum or sodium 
alginate are included in the system along with calcium carbonate, 
sodium bicarbonate and acid neutralizers, which forms a foaming 
sodium alginate or gellan gel raft when come in contact with gastric 
fluids. The raft floats on the gastric fluids and prevents the reflux of 
the gastric contents (i.e. gastric acid) into the esophagus by acting 
as a barrier between the stomach and esophagus.[60] 
Different Approaches For In-Situ Gelling System 
 
 
 
Figure.3. Mechanism of drug release from matrix  
 
There are different mechanisms reported for the formation of in-situ 
gel formation: 
Chemical reaction (e.g., Ionic cross linking method) 
Physiological stimuli  
Temperature-sensitive. 
pH-sensitive. 
Ion-sensitive. 
Dilution sensitive. 
Electrical signal-sensitive. 
Light-sensitive. 
Glucose-sensitive. 
 
In-Situ Gelling Based On Chemical Stimuli 
Ionic Cross-Linking 
Certain ion sensitive polysaccharides such as carrageenan, gellan 
gum (Gelrite),pectin, sodium alginate undergo phase transition in 
presence of different ions such as K+, Ca+2, Mg+2, Na+. e.g., 
Gelation of low- methoxy pectins can be caused by divalent 
cations, especially Ca+2 ions, alginic acid undergo gelation in 
presence of divalent/ polyvalent cations, e.g., Ca+2due to the 
interaction with guluronic acid block in alginate chains. E.g., 
Haoping Xu(2014) studied novel in-situ gel for formulation of 
ranitidine oral drug delivery.[35] 
In-Situ Gel Formation Based On Physiological Stimuli 
Temperature-sensitive 
Temperature is one of the most widely used stimuli-sensitive in situ 
gels, because it is easy to control and has practical advantages 
both in vitro and in vivo. These formulations are liquid at room 
temperature (20-25oC) and undergo gelation when comes in 
contact with application site (35-37oC), due to increase in 
temperature. Temperature sensitive in-situ gel undergoes a volume 
phase-transition or a sol-gel phase transition at a critical solution 
temperature (UCST). The LCST polymers exhibit a hydrophilic to 
hydrophobic transition with increasing temperature, whereas the 
UCST systems undergo the opposite transition. There are different 
polymers used as LCST such as poly (N-isopropyl acryl amide) 
Shendge et al. International Journal of Drug Delivery 6 (3) 230-243 [2014] 
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(PNIPAM), poly (N,N diethylacrylamide) (PDEAM), poly(vinyl ether) 
(PVE), poly(N-vinylalkylamide) (PNVAAM), polyphoaphazene 
derivatives and poly(N-(2-hydroxypropyl)methacrylamide mono/di 
lactate) (PHVAAM)-mono/dilactate). Among all poloxamers are the 
most commonly used thermosetting polymers in in-situ gel forming 
drug delivery system.  
Mechanisms involved in sol to gel transition after an increase in 
temperature. 
Gradual desolation of the polymer.  
Increased micellar aggregation. 
The increased entanglement of the polymeric network. 
Thermo reversible gels can be prepared with naturally occurring 
polymers such as gelatin and carrageenan. At elevated 
temperature these polymers adopt a random coil conformation in 
solution. Upon cooling, a continuous network is formed by partial 
helix formation. Latest study on thermo-sensitive FDDS is 
preparation and development of organogel or ganogel for treatment 
of schizophrenia by using long chain fatty acids in pharmaceutical 
oil.[8, 63] 
PH-sensitive  
pH is one of the important environmental parameter for novel drug 
delivery system, because the pH  change occurs at different body 
sites such as stomach, intestine, endosome, blood vessels, vagina 
and tumor extracellular sites. These formulations are polymeric 
dispersion in aqueous system which undergoes spontaneous 
gelation in response to change in pH after application at the target 
site. Generally the ionic polymers like polyacrylamide, polyacrylic 
acid, and polymethacrylic acid are used for preparation of pH 
sensitive in-situ gels.  The entire pH sensitive polymers acidic or 
basic group either accepts or release protons in response to 
change in environmental pH. Swelling of in-situ gel increases as 
the external pH increases in the case of weakly acidic (anionic) 
groups, but decreases if polymer contains weakly basic (cationic) 
groups. Singh NK studied the pH and temperature sensitive 
biodegradable copolymer hydrogel for drug delivery.[63] 
Ion-sensitive 
In such type of in-situ hydrogels the sol to gel transition occurs due 
to presence of mono/di valent cations such as Na+, K+, Ca++, and 
Mg++  ions. Naturally occurring anionic polymers like gellan gum, 
sodium alginate, carrageenan and xyloglucan have properties of 
cationic induced gelation. Gellan gum is commercially available as 
Gelrite® is an anionic polysaccharide that undergoes in-situ gelling 
in the presence of mono and divalent cations including Ca2+, Mg2+, 
K+  and Na+. 
Dilution sensitive  
This type of hydrogel contains polymer that undergoes phase 
transition in presence of higher amount of water. System that 
undergoes phase transition as a consequence of dilution with water 
a higher amount of polymer can be used. E.g., Lutrol F68. 
Electrical signal sensitive 
This type of transmission occurs in presence of an applied 
electrical field. Chitoson gels can be used for electrically modulated 
drug delivery through gel matrix. 
Light sensitive 
Light- sensitive hydrogels can be used in the development of 
photo- responsive artificial muscle or as the in-situ forming gels 
cartilage tissue engineering. Polymerizable functional groups and 
their initiator like ethyl eosin and camphor quinine can be injected 
in to tissue and then electromagnetic radiations are applied to form 
a gel by enzymatic processes. For this purpose long ultraviolet 
wavelengths are used.  
Glucose- sensitive 
The stimuli-responsive system to release the insulin intelligently 
using hydrogels has been investigated. Cationic pH sensitive 
polymers containing immobilized insulin and glucose oxidase can 
swell in response to blood glucose level releasing the entrapped 
insulin in pulsatile manner.  Another approach is based on 
competitive binding of insulin or insulin and glucose to fix the 
number of binding sites in concanavatin A , where insulin is 
displaced in response to glucose stimuli, thus functioning as a self-
regulating insulin delivery system. An alternative route through 
phenyl borate-poly (vinyl alcohol) polymers is also possible.  
novel trend in floating drug delivery system  
Floating drug delivery system is mostly used system for controlled 
and sustained drug delivery. In situ gelling system is a novel trend 
in FDDS. Different polymers are used in floating in situ gelling 
preparation for different approaches. 
Polymers used as in situ gelling agents 
Materials which undergo sol to gel transition in aqueous solution at 
body temperature are used in the development of sustained 
release vehicle with in situ gelation property. 
 Some polymers are listed below which are used as in situ gelling 
agents 
 
1.  Pectin 
2.  Gellan gum  
3. Sodium alginate  
4.  Xyloglucan 
5.  Pluronic F127 
6.  Xanthan gum 
7.  Chitosan 
8.  Carbomer 
Pectin  
Low methoxy pectin (degree of esterification < 50%) Low 
methoxypectins (degree of esterification <50%) readily form gels in 
Shendge et al. International Journal of Drug Delivery 6 (3) 230-243 [2014] 
 
 
  
PAGE | 236 |
 
aqueous solution in the presence of free calcium ions, which 
crosslink the galacturonic acid chains in a manner described by 
egg-box model . The main advantage of using pectin for these 
formulations is that it is water soluble, so organic solvents are not 
necessary in the formulation. Divalent cations present in the 
stomach, carry out the transition of pectin to gel state when it is 
administered orally. Sodium citrate may be added to the pectin 
solution to form a complex with most of calcium ions added in the 
formulation. By this means, the formulation may be maintained in a 
fluid state (sol), until the breakdown of the complex in the acidic 
environment of the stomach, where release of calcium ions causes 
gelation to occur. The potential of an orally administered in situ 
gelling pectin formulation for the sustained delivery of Paracetamol 
has been reported. 
Pectin is a complex polysaccharide comprising mainly esterified D-
galacturonic acid residues in an a-(1ă4) chain. Pectin gelation 
characteristics can be divided into two types: high-methoxy and 
low-methoxy gelation. Gelation of high methoxy pectin usually 
occurs at pH < 3.5. Low-methoxy pectin is gelled with calcium ions 
and is not dependent on the presence of acid or high solids 
content.  
 
 
 
Figure. No.4: Chemical structure of pectin 
 
Gellan gum 
Gellan gum (GelriteR) is a linear, anionic heteropolysaccharide 
secreted by the microbe Sphingomonas elodea (formerly known as 
Pseudomonas elodea). The native polysaccharide is partially 
esterified with L-glycerate and acetate, but the commercial product 
Gelrite has been completely de-esterified by alkali treatment. 
GelriteR (deacetylated gellan gum) is one of the most interesting in 
situ gelling polymers that have been tested since it seems to 
perform very well in humans. Formulations with the Gelrite can be 
administered to ocular mucosa as a low viscosity solution. On 
contact with cations in tear fluid the formulation will form a clear 
gel. This is caused by cross linking of the negatively charged 
polysaccharide helices by monovalent and divalent cations (Na+, 
K+, Ca2+). Gellan gum produces temperature dependent or 
cations induced in situ gelling. It is a water soluble polysaccharide. 
It forms a gel via formation of double helices, followed by their ionic 
cross-linking. [60, 71] 
 
 
Figure. No.5: Chemical structure of  Gellan gum 
Sodium alginate: ( Alginic acid)  
Alginic acid is a polysaccharide consisting of β-D-mannuronicacid 
(M) and đ-L-guluronic acid (G) residues joined by 1,4-glycosidic 
linkage. Alginate is a well known polysaccharide widely used due 
to its gelling properties in aqueous solutions related to the 
interactions between the carboxylic acid moieties and bivalent 
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counter ions, such as calcium, lead, and copper; it is also possible 
to obtain an alginic acid gel by lowering the environmental pH 
value. Alginate has been proposed in the field of pharmaceutics for 
its in situ gelation properties, particularly for the application of 
alginate gels for ocular drug delivery, since this dosage form is so 
effective as compared to solutions. A prolonged delivery of two 
different drugs (pilocarpine40 and carteolol41) was obtained in 
comparison to the same drugs instilled as solutions. Alginic acid is 
mucoadhesive, biodegradable and non toxic polymer. Because of 
these applications it is widely used as a vehicle for ophthalmic in 
situ gelling system. Sodium alginate has been employed in the 
preparation of gels for the delivery of biomolecules such as drugs, 
peptides and proteins. [71] 
 
 
Figure. No.6: Chemical structure of  Sodium alginate 
 
Xyloglucan 
Xyloglucan is a polysaccharide derived from tamarind seeds and it 
is composed of a (1ā4)-β-D-glucan backbone which has (1ā6)-đ-D-
xylose branches that are partially substituted by (1ā2)-β-D-
galactoxylose46. Xyloglucan forms thermo responsive gels in 
water, under certain conditions. For example, the solăgel transition 
of xyloglucan was shown to decrease from 40 ĈC to 5 ĈC when the 
galactose removal ratio increased from 35 to 58%. Xyloglucan 
formulations were assessed for ocular delivery of pilocarpine; using 
Poloxamer 407 as a positive thermosensitive control. The 1.5 wt. % 
xyloglucan formulation enhanced the miotic response to a degree 
similar to that of a 25 wt. % Poloxamer 407 gel49. In comparison 
with gellan and alginate, in the oral administration of cimetidine, 
xyloglucan gels appear to be the system with the widest application 
because its gelation does not require the presence of cations, as in 
the case of alginate, and its use is not restricted by the charged 
nature of the drug, as in the case of gellan. Xyloglucan gels have 
also been investigated for ocular delivery of pilocarpine and timolol. 
Xyloglucan gels have also been used as vehicles for a sustained 
release of percutaneous formulations of non-steroidal anti-
inflammatory drugs. [73] 
 
 
 
Figure. No.7: Chemical structure of Xyloglucan 
 
 
Pluronic F127 The Poloxamers or pluronic consist of more than 30 different non-
ionic surface active agents. Poloxamers, commercially available as 
PluronicR, are the most commonly used thermal setting polymers 
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in ophthalmology. They are formed by central hydrophobic part 
(polyoxypropylene) surrounded by hydrophilic part (ethylene 
oxide). Pluronic F-127, which gives colorless and transparent gels, 
is the most commonly used polymer in pharmaceutical technology. 
Poloxamer formulation generally increased drug residence time at 
application sites, resulting in improved bioavailability and efficacy. 
(PluronicR F127) was found to gel at a concentration of 20 wt. % at 
25 ĈC, which is less than that of the other members of the 
Poloxamer series. At room temperature (25ĈC), the solution 
behaves as a mobile viscous liquid, which is transformed into a 
semisolid transparent gel at body temperature (37ĈC). Pluronics or 
Poloxamers also undergo in situ gelation by temperature change. 
Pluronic F-127 was used as an in situ gel forming polymer together 
with mucoadhesive polymers such as Carbopol 934 and hydroxyl 
propyl methylcellulose to ensure long residence time at the 
application site. [70-71] As shown in figure No. 8 
 
Figure.No.8 PEO-PPO-PEO (Poloxamer) 
 
Synthetic polymers  
Synthetic polymers are of increasing interest in drug delivery as 
therapeutic agent. Synthetic polymers are popular choice mainly 
for parenteral preparations. Aliphatic polyesters such as poly (lactic 
acid), poly (glycolic acid), poly (lactide- coglycolide), poly 
(decalactone), poly ē-caprolactone have been the subject of the 
most extensive recent investigations68.Various other polymers like 
triblock polymer systems composed of poly (D,L-lactide)-block poly 
(ethylene glycol)-block-poly (DL-lactide), blends of low molecular 
weight poly (D,L-lactide) and poly (ē-caprolactone) are also in use. 
These polymers are mainly used for the injectable in situ 
formulations. The feasibility of lactide/glycolide polymers as 
excipients for the controlled release of bioactive agents is well 
proven. [71] 
 
FORMULATION  
 
 
 
 
 
 
 
 
 
Evaluation Of Floating In-Situ Gelling System 
Clarity 
Clarity is inspected visually under black and white backgrounds. 
Texture analysis 
The consistency, cohesiveness and firmness are checked by 
texture analyzer which mainly indicates syringability of solution to 
know its ease of administration in vivo. 
Drug polymer interaction and thermal analysis 
Drug-polymer interaction studies can be done by FTIR 
spectroscopy. TGA can be done to quantitate the percentage of 
water in hydrogel. DSC is conducted to observe whether there are 
any changes in themograms as compared with pure active 
ingredients used for gelation purpose. 
Determination of drug content 
Certain amount of formulation is added to the amount equivalent to 
drug has to be dissolved in suitable medium and stir for required 
time and then filtered.  Then analyze for drug content.  
pH determination 
The pH can be measured by using digital pH meter and at 
favorable condition. The influence of pH on the gelation property of 
sol can be determined by using different medium of various pH 
valves.  
In-vitro gelling capacity: Generally 
To prepare a polymeric solution in 
deionized water  
Calcium carbonate and drug dissolved in above 
polymeric solution with stirring 
Finally, preservatives added and store the solution.
Heat the polymer solution at 600C with 
stirring 
Then cool the 
solution at 400C 
Shendge et al. International Journal of Drug Delivery 6 (3) 230-243 [2014] 
 
 
  
PAGE | 239 |
 
gelling capacity of an in situ gel forming system can be determined 
by forming a colored solution of in situ gelling system for visual 
observation. By adding in situ gel to simulated gastric fluid we can 
estimate different parameters like in situ gel formation, its stiffness 
and the duration for which formed gel remain intact.  
In-vitro buoyancy studies 
After addition of in-situ gelling formulation to a simulated gastric 
fluid we can estimate parameters such as floating lag time and the 
time the gel float on system constantly.  
In-vitro drug release studies 
The release rate of drug from in-situ gel can be determined using 
USP dissolution rate testing apparatus II at 50 rpm. 900ml of 0.1 N 
HCl can be used as dissolution medium and temperature of 37+0.5 
0 C is maintained. 5ml samples can be withdrawn at various time 
points for estimating the drug release using UV-Visible 
spectrophotometer. The drug release studies from in-situ gel can 
also be done by using plastic dialysis cell.  
Measurement of rheological property of sol and gel 
Viscosity of in-situ formulation can be measured by using 
Brookfield viscometer, Cone and plate viscometer etc., the 
viscosity of the gel can also be determined to estimate the gel 
strength.  
Water uptake study 
 When sol is converted to gel, it is collected from the medium and 
the excess medium was blotted using a tissue paper. The initial 
weight of gel so formed has to be noted. Again the gel has to be 
exposed to the medium and the same procedure is repeated for 
every 30 min to note down the weight of the gel at each interval 
after removing the medium using filter paper. Effect of pH, 
concentration of gelling agent/ cross linking agent on viscosity, in 
situ gelation character, floating ability and drug release can be 
studied for in situ gelling type of floating formulation. 
Gel strength 
Gel strength is evaluated by using rheometer with a specified 
amount of solution form gel where prepared in a beaker. This 
beaker is raised so pushing the probe of rheometer through the 
gel. Change in the load on probe can be measured as a function of 
depth of merge of the probe below the gel surface.  
Sol-gel transition temperature and gelling time 
Sol to gel transition temperature is the temperature at which the 
phase transition of sol meniscus is first noted when it kept in a 
sample tube at a specific temperature and then heated at a 
specified time. Gel formation is indicated by a lack of movement of 
meniscus on tilting the tube. Gelling time is the required for first 
detection of gel formation of sol formation. 
Accelerated stability studies 
Formulation are placed in amber color vials and sealed with 
aluminum foil for short term accelerated stability study at 40oC and 
75 % RH as per ICH guidelines. Samples are tested for every 
month for clarity, pH, gelling capacity, drug content, viscosity and in 
vitro dissolution studies.  
Application Of Floating In-Situ  
To increase the absorption of drugs which are mostly absorbed 
from upper GIT to get prolonged contact time at their site of 
maximum absorption and so increase the extent of drug 
absorption. 
As there is increase in absorption of drug from specific site the 
bioavailability of drug enhanced probably. Increase in gastric transit 
time also causes an increase in the bioavailability of drug. 
As drug remain in stomach till completely release, so frequency of 
adverse effect on colon is reduced. 
Drugs that are released in the stomach get enough residence time 
for absorption rate occurs. Local action of drug is prolonged, so 
less amount of dose is required for administration.  
Advantages Of Fdds 
The floating systems are important tool of stomach specific drug 
delivery, both for systemic as well as local drug action. E.g. 
antacids 
Acidic substances generally cause irritation on the stomach wall 
when it comes in contact with it. So there is scope for the 
development of HBS formulation for acidic drugs like aspirin and 
some other drugs. 
The prolong release dosage forms as tablets or capsules on 
administration will dissolve in gastric fluid. After dissolution they will 
be available in gastric fluid to be dissolved in small intestine after 
emptying of stomach contents. The drug will be fully absorbed from 
floating dosage form if it remains in solution form in alkaline pH of 
intestine. 
The drugs meant for local action as H2-receptor antagonist or 
some other drugs for local action have advantageous for GRDDS. 
When there is a vigorous intestinal movement and a short transit 
time as might occur in certain type of diarrhea, poor absorption is 
expected. Under such circumstances it may be advantageous to 
keep the drug in floating condition in stomach to get a relatively 
better response. 
Dosing frequency is reduced in this system and thus increases the 
patient compliance. 
The first pass effect is reduced as bioavailability of drug is 
enhanced by maintenance of desirable plasma drug concentration 
with continues drug release by this system.    
Better therapeutic effect of short half-life drugs can be achieved. 
Due to buoyancy gastric retention time is increased. 
Drugs which have stomach as main absorption site, FDDS is 
advantageous for it.  
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Superior to single unit floating dosage forms as such microspheres 
releases drug uniformly and there is no risk of dose dumping. 
Gastric irritation is minimized as these dosage forms show 
sustained drug release, buoyancy and uniform drug release 
through multi-particulate system.  
Advantages Of Floating In Situ Gel  
As the in-situ gel has low density it floats immediately on gastric 
fluid to form a layer on it. It has effective surface area which leads 
to high drug release and improved bioavailability.  
Buoyancy is faster than tablets and capsules.  
Easy method of preparation then other floating dosage forms. 
Conclusion 
It is challenge to prepare a dosage form which gives prolonged 
gastric retention as well as compatibility with stomach physiology. 
To obtain gastric retention researchers have worked from several 
years and had developed different approaches for GRDDS.  Out of 
which floating in-situ gelling system is most promising technique 
which undergoes sol to gel transition when come in contact with 
gastric fluid or stomach pH. These gels shows site specific drug 
delivery may be local or systemic delivery as it retain in stomach 
for long period of time by floating on gastric fluid. This reduces 
dosing frequency and hence patient compliance. In-situ gels are 
useful for sustained drug delivery and also beneficial for pediatric 
and geriatric drug delivery.  Different biodegradable polymers are 
used in in-situ floating systems. The floating behavior of 
biodegradable polymer can be further studied for improvement of 
gastric retention and hence bioavailability of different drugs. In-situ 
gels are promising dosage for in the field of novel controlled drug 
delivery systems as it as good stability and bioavailability along 
with better drug release which makes it more reliable one amongst 
other conventional dosage forms. 
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